AbCellera Biologics Inc. (ABCL) vs Heartflow, Inc. Common Stock (HTFL)
A side-by-side comparison of AbCellera Biologics Inc. and Heartflow, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABCL
AbCellera Biologics Inc.
$13.79HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
HTFL
Heartflow, Inc. Common Stock
$52.42HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — ABCL vs HTFL
growth of $100 · dividends reinvested · last 1yABCL +224.2% (+224.2%/yr)HTFL +81.6% (+81.6%/yr)ABCL compounded faster over this window
ABCL HTFL
ABCL vs HTFL: by the numbers
- •HTFL is the larger company ($4.52B vs $4.21B market cap).
- •Both run net losses; HTFL's is the smaller (-55.82% vs -248.83% net margin).
Metrics side by side
Valuation
| Metric | ABCL | HTFL |
|---|---|---|
| P/S ratio | 63.64 | 21.32 |
| P/B ratio | 4.70 | 16.16 |
Profitability
| Metric | ABCL | HTFL |
|---|---|---|
| Gross margin | 61.64% | 80.08% |
| Operating margin | -288.98% | -34.31% |
| Net margin | -248.83% | -55.82% |
| ROE | -18.38% | -42.32% |
| ROIC | -17.95% | -23.69% |
Growth (annualized)
| Metric | ABCL | HTFL |
|---|---|---|
| Revenue CAGR (5Y) | -31.78% | N/A |
| Total return CAGR (5Y) | -3.57% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.